MENU
KMDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kamada (KMDA) Ownership - Who owns Kamada?
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
417.56M
P/E Ratio
26.36
Total Cash
76.25M
Projected Growth
0.89
Total Debt
11.1M
Revenue
167.24M
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
1.33
Total Debt/Equity
18.61
Revenue/Share
2.92 USD as % of share price
Fundamentals
KMDA
Capitalization
418M
P/E Ratio
26.36
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash
76.2M
Total Cash/Share
1.33
Total Debt
11.1M
Total Debt/Equity
18.61
Projected Growth (PEG Ratio)
0.89
Revenue/Share (as % of the share price)
2.92%
Revenue
167M
ROE
N/A
Book Value
252M
P/B Ratio
1.68
Cash Flow
N/A
Earnings
0.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
15.1M
Current Ratio
3.30
Current Revenue Per Employee
117695.19
Dividends Per Share - Security
N/A
EBITDA
32.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
47.14
Revenue To Assets
4.47
Shares Held By Institutions
52.8M
Shares Outstanding - Current
57.5M
Total Liabilities
123M
Total Volume MTD
N/A
Value
-1
Gain YTD
23.303
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KMDA showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company, which engages in pharmaceutical business
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com